722525-94-2

Upstream product

• 595582-27-7 (+)-(3R,4S,5S,6R)-3-O-acetylclausenamide 
• 1579151-60-2 (+)-(3R,4S,5S)-3-O-acetylclausenamidone 
• 130273-48-2 (3R,4S,5S)-clausenamidone 

Downstream Products

• 722526-00-3 (-)-(3R,4S)-Δ^5,6clausenamide 
• 722526-12-7 (±)-(3R,4R,5S,6R)-5-hydroxyclausenamide 
• 722526-06-9 (-)-(3R,4R,5R,6S)-5-hydroxyclausenamide 
• 722526-17-2 (+)-(3R,4R,5R,6S)-3-O-acetyl-5-hydroxyclausenamide 
• 1579151-64-6 (+)-(3R,4R,5S,6R)-3-O-acetyl-5-hydroxyclausenamide 
• 722526-30-9 (+)-(3R,4R,5R)-3-O-acetyl-5-hydroxyclausenamidone 
• 722526-35-4 (+)-(3R,4R,5R,6R)-3-O-acetyl-5-hydroxyclausenamide 
• 595582-28-8 (±)-(3R,4R,5R,6R)-5-hydroxyclausenamide 

Relevant academic research and scientific papers

Studies on the synthesis and biological evaluation of the metabolite of clausenamide CM2 and its stereoisomers

The synthesis and biological evaluation of 5-hydroxy clausenamide (CM 2), one of the major metabolites of clausenamide, and its stereoisomers have been carried out. The absolute configurations of (-)- and (+)-CM2 were assigned as 3S,

CLAUSENAMIDE C5 HYDROXYL DERIVATIVES AND N-SUBSTITUTED DERIVATIVES, PROCESSES FOR THEIR PREPARATION, ITS COMPOSITION AND USE

The present invention relates to stereo isomers of C5-hydroxyl substituents, N-substituted derivatives of hydroxybenzyl, hydroxyl, phenyl substituted γ-lactams (clausenamide) and the preparation methods thereof, and pharmaceutical compositions